首页> 美国卫生研究院文献>Oncology Letters >Surgery in patients with small cell lung cancer: A period propensity score matching analysis of the Seer database 2010-2015
【2h】

Surgery in patients with small cell lung cancer: A period propensity score matching analysis of the Seer database 2010-2015

机译:小细胞肺癌患者的手术:Seer数据库的期间倾向评分匹配分析2010-2015年

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Surgery as a therapeutic modality for non-small cell lung cancer is widely accepted in clinical practice. However, the role of surgery for small cell lung cancer (SCLC) remains controversial. Therefore, in the present study a period propensity score matching analysis using the Surveillance, Epidemiology and End Results (SEER) Registry database was performed to investigate the role of surgery on survival in patients with SCLC. Patients with SCLC between January 2010 and December 2015 were identified from the SEER database, and individual data for each case regarding general clinical characteristics, surgery of primary site (SPS), cause-specific death classification and survival time were retrieved. Differences of cause-specific survival (CSS) between subgroups were estimated by the log-rank test. Cox regression analysis was used to evaluate the effects of multiple variables on CSS, and differences between the incidences of cause-specific death were examined using a χ2 test. A total of 1,707 records met the inclusion criteria and were retrieved for analysis. There were significant differences of CSS in the clinicopathological features of N (P=0.01), Stage (P<0.01) and Surgery (P<0.01) when comparing non-surgery with surgery, and in N (P<0.001), Stage (P=0.006) and Surgery (P=0.049) when comparing sublobectomy with lobectomy or bilobectomy (lobe/s). Patients who did not receive surgery (P<0.001) or who received sublobectomy (P=0.03) had an increased risk of mortality when compared with patients who received surgery and lobe/s. The findings of the present study indicate that surgery should be taken into consideration when an initial treatment strategy is made in patients for patients with SCLC at clinical stage I–IIA (T1-2,N0,M0), regardless of whether they are >50 years of age, their sex, histology and grade. The results suggest that certain patients with SCLC with stage IIB (N1) can also benefit from lobe/s, although further investigation is required. In addition, lobe/s is preferable to sublobectomy when surgery is performed. However, the present study was unable to comprehensively analyze the efficacy of pneumonectomy for SCLC.
机译:手术作为非小细胞肺癌的治疗手段已在临床实践中被广泛接受。然而,手术对小细胞肺癌(SCLC)的作用仍存在争议。因此,在本研究中,进行了一项使用监视,流行病学和最终结果(SEER)注册数据库的时期倾向评分匹配分析,以调查手术对SCLC患者生存的作用。从SEER数据库中识别出2010年1月至2015年12月期间的SCLC患者,并检索了每例病例的有关一般临床特征,原发部位手术(SPS),特定原因死亡分类和生存时间的个人数据。通过对数秩检验评估亚组之间特定原因生存(CSS)的差异。用Cox回归分析法评估多变量对CSS的影响,并通过χ 2 检验检查特定原因死亡的发生率之间的差异。符合纳入标准的共有1707条记录,并进行了分析。比较非手术与手术相比,CSS在N(P = 0.01),分期(P <0.01)和手术(P <0.01)的临床病理特征上有显着差异,而在N(P <0.001),分期(P <0.001)比较肺叶下切除术与肺叶切除术或双叶切除术(肺叶/秒)时的P = 0.006)和手术(P = 0.049)。与接受手术和肺叶/秒的患者相比,未接受手术的患者(P <0.001)或接受肺叶切除术的患者(P = 0.03)的死亡风险增加。本研究的结果表明,在临床阶段I–IIA(T1-2,N0,M0)的SCLC患者中采取初始治疗策略时,无论是否> 50,都应考虑手术治疗年龄,性别,组织学和等级。结果表明,尽管需要进一步研究,某些患有IIB期(N1)SCLC的患者也可以从肺叶获益。另外,在进行手术时,肺叶比肺叶下切除术更可取。但是,本研究无法全面分析肺切除术对SCLC的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号